TheSFPM Profile Banner
The Society for Functional Precision Medicine Profile
The Society for Functional Precision Medicine

@TheSFPM

Followers
903
Following
465
Media
71
Statuses
677

Functional assays to improve patient outcomes. Join us: https://t.co/XoLE8MKHAv

Joined February 2018
Don't wanna be here? Send us removal request.
@TheSFPM
The Society for Functional Precision Medicine
3 days
Voting is now open for the SFPM Elections! This is your chance to help shape the future of our organization by selecting the leaders who will represent and guide our mission. If you are a Member, cast your vote today! Vote now:
0
0
0
@JoanMonte
Joan Montero
2 months
Congratulations @DrTonyLetai ! I wish you every success in this new endeavor and I have no doubt that your vision, leadership and integrity will bring great value to the NCI. I'm deeply grateful for your invaluable mentorship, friendship and encouragement over the years. Amazing!
@TheSFPM
The Society for Functional Precision Medicine
2 months
The Society for Functional Precision Medicine (SfPM) congratulates our President, @DrTonyLetai, on his appointment as Director of the National Cancer Institute (NCI) /thread https://t.co/DmJFuMhZG6
0
1
6
@TheSFPM
The Society for Functional Precision Medicine
2 months
@DrTonyLetai In light of this transition, new Board openings will be announced, with elections to follow. SfPM members will receive additional details in the coming weeks. Stay tuned:
Tweet card summary image
sfpm.io
The SFPM arose to match cancer patients to their best therapies. Using patient-derived models, including organoids and 2D culture; and many readouts, including metabolic, morphologic and cell death...
0
0
2
@TheSFPM
The Society for Functional Precision Medicine
2 months
@DrTonyLetai We are inspired to see Dr. Letai bring his stabilizing, trailblazing force to the NCI at such a critical time for cancer research. Please join us in thanking him for his service to SfPM and congratulating him on this momentous new chapter.
1
0
1
@TheSFPM
The Society for Functional Precision Medicine
2 months
@DrTonyLetai His leadership has strengthened our community and accelerated progress toward a future where functional precision medicine improves outcomes for patients everywhere.
1
0
0
@TheSFPM
The Society for Functional Precision Medicine
2 months
@DrTonyLetai While we are saddened to see him step away from his role at SfPM, we are profoundly grateful for his years of service and unwavering support of our mission.
1
0
0
@TheSFPM
The Society for Functional Precision Medicine
2 months
@DrTonyLetai This announcement, shared moments ago by the NCI, marks an historic moment for cancer research. Dr. Letai has been a tireless advocate and visionary leader for functional precision medicine, advancing our field with conviction, generosity, and transformative insight.
1
0
0
@TheSFPM
The Society for Functional Precision Medicine
2 months
The Society for Functional Precision Medicine (SfPM) congratulates our President, @DrTonyLetai, on his appointment as Director of the National Cancer Institute (NCI) /thread https://t.co/DmJFuMhZG6
Tweet card summary image
nih.gov
Dr. Letai will serve as NCI’s 18th director.
1
0
2
@JoanMonte
Joan Montero
5 months
🚨 New Article Alert! Dive into a fantastic review by several @TheSFPM members on how new technologies and functional approaches are revolutionizing personalized cancer treatment. Don't miss out on this game-changing insight! https://t.co/CcPsCQZbYR
Tweet card summary image
nature.com
Nature Reviews Cancer - Acquired therapeutic resistance is a key contributor to cancer treatment failure, requiring new approaches to address its complex mechanisms. In this Roadmap, Soragni,...
0
1
2
@TheSFPM
The Society for Functional Precision Medicine
8 months
Join us *today* Wednesday 03/12 @ 12:00 PM EST for our monthly SFPM seminar! Dr. Perova from @emblebi will discuss: "Leveraging https://t.co/V7lwNqdBaB: enhancing precision oncology through collaborative cancer model resources" https://t.co/ohnuFm6QxS
sfpm.io
The SFPM Seminar series is for those interested in the use of assaying technology to further biomarker discovery, drug R&D and personalized healthcare outcomes.
0
0
1
@oncodaily
OncoDaily
9 months
Exploring high-throughput drug sensitivity testing in neuroblastoma cell lines - Karin Langenberg-Ververgaert @TheSFPM @prinsesmaximac https://t.co/k8pAq4ZvSj #Cancer #CancerResearch #Medicine #Health #Neuroblastoma #BrainTumor #Oncology #OncoDaily
0
1
17
@TheSFPM
The Society for Functional Precision Medicine
9 months
Join us *today* Wednesday 02/12 @ 12:00 PM EST for our monthly SFPM seminar! Dr. Andrew Satterlee from @UNC will discuss overcoming systemic barriers to functional precision medicine using a versatile ex vivo model of patient brain tumors
1
0
0
@TheSFPM
The Society for Functional Precision Medicine
10 months
An exciting multicenter phase 2 functional precision medicine clinical trial showing how a rapid ex vivo venetoclax sensitivity assay was the strongest predictor for a favorable treatment response and survival in relapsed/refractory secondary AML https://t.co/ccEG0vbCdU
Tweet card summary image
ashpublications.org
Key PointsBlast-specific ex vivo venetoclax sensitivity correlated strongly with treatment responses and predicted longer survival.VenEx trial showed that
4
1
1
@TheSFPM
The Society for Functional Precision Medicine
11 months
Join us *tomorrow* Wednesday 12/11 @ 12:00 PM EST for our last monthly SFPM seminar of the year! Drs. Damle and Pillarisetty from @fredhutch will discuss tumor slice cultures as a window into the human TME. Info to join here:
sfpm.io
The SFPM Seminar series is for those interested in the use of assaying technology to further biomarker discovery, drug R&D and personalized healthcare outcomes.
0
0
0
@NiTriona
Triona Ní Chonghaile
1 year
Joan Montero describing his huge contributions to the cell death field and the discovery of dynamic BH3 profiling that has huge potential for precision medicine @JoanMonte @TheSFPM
@ApoReunion
XV ApoRed meeting
1 year
Joan Montero @JoanMonte, from @UniBarcelona, explains how Apoptotic protection in therapy-induced senescent melanoma cells is mediated through BCL-xL binding to BAK
1
2
18
@AACR
AACR
1 year
Submit an abstract by November 15 for the AACR Special Conference on Functional and Genomic Precision Medicine in Cancer (March 11-13, Boston), chaired by Anthony Letai, Elaine Mardis, Peter Horak, and Alice Soragni. https://t.co/vA0IuZHk9i #AACRprecmed25 @DrTonyLetai @soragnilab
0
2
3
@TheSFPM
The Society for Functional Precision Medicine
1 year
Beautiful study from @TheSFPM member @ritafior on zebrafish-powered functional precision medicine
@ritafior
FiorLAB
1 year
🚨NEW study from our LAB showing the predictive value of Patient-derived Breast Cancer 🐟zebrafish Avatars ! A co-clinical study where we compare the patient clinical response to treatment with their matching 🐟zAvatar! ✨100% @ChampalimaudF @TheSFPM https://t.co/XTlfR8GE1W
0
1
4
@TheSFPM
The Society for Functional Precision Medicine
1 year
Mark your calendars for the next Functional Precision Medicine meeting (March 11-13, 2025)! Submit your abstract by November 15th #FPM
@AACR
AACR
1 year
Submit an abstract by November 15 for the AACR Special Conference on Functional and Genomic Precision Medicine in Cancer (March 11-13, Boston), chaired by Anthony Letai, Elaine Mardis, Peter Horak, and Alice Soragni. https://t.co/yQwl4kkfIa #AACRprecmed25 @DrTonyLetai @soragnilab
0
1
3
@JoanMonte
Joan Montero
1 year
What an inspiring week at the EHA-SFPM Congress in Copenhagen! Thank you to all the researchers, clinicians, and innovators who continue to push the limits of what’s possible. The future of science is collaborative & I’m excited for what’s coming . #PrecisionMedicine #EHASFPM
3
6
28